An Open-Label Trial of Aripiprazole Monotherapy in Children and Adolescents with Bipolar Disorder

Abstract

Open-label aripiprazole treatment was beneficial in the treatment of mania in youth with bipolar disorder. Future placebo-controlled, double-blind studies are warranted.